Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too!
- PMID: 35323013
- PMCID: PMC9017291
- DOI: 10.1128/aac.00213-22
Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too!
Keywords: Enterobacterales; World Health Organization; antibiotic resistance; carbapenem; cephalosporin; pathogen; pipeline; third generation.
Conflict of interest statement
The authors declare a conflict of interest. A.B. is a paid consultant for Allecra Therapeutics SAS. K.S.K. is a paid consultant for Allecra Therapeutics SAS, Utility Therapeutics, Merck, Qpex, and Shionogi and has received grant support from Merck.
Comment in
-
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too!".Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0022322. doi: 10.1128/aac.00223-22. Epub 2022 Mar 24. Antimicrob Agents Chemother. 2022. PMID: 35323014 Free PMC article. No abstract available.
Comment on
-
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed.Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0199121. doi: 10.1128/AAC.01991-21. Epub 2022 Jan 10. Antimicrob Agents Chemother. 2022. PMID: 35007139 Free PMC article. Review.
Similar articles
-
The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgery.Clin Microbiol Infect. 2021 Oct;27(10):1481-1487. doi: 10.1016/j.cmi.2021.02.002. Epub 2021 Feb 12. Clin Microbiol Infect. 2021. PMID: 33588061
-
Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study.Lancet Glob Health. 2018 Sep;6(9):e969-e979. doi: 10.1016/S2214-109X(18)30278-X. Lancet Glob Health. 2018. PMID: 30103998
-
Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of Enterobacterales Expressing Extended-Spectrum β-Lactamases and Serine Carbapenemases.Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0055221. doi: 10.1128/AAC.00552-21. Epub 2021 Jul 16. Antimicrob Agents Chemother. 2021. PMID: 34001510 Free PMC article.
-
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.
-
Phenotypic and genotypic characterisation of cephalosporin-, carbapenem- and colistin-resistant Gram-negative bacterial pathogens in Lebanon, Jordan and Iraq.J Glob Antimicrob Resist. 2021 Dec;27:175-199. doi: 10.1016/j.jgar.2021.08.005. Epub 2021 Sep 1. J Glob Antimicrob Resist. 2021. PMID: 34481122 Review.
Cited by
-
Multidrug-resistant Gram-negative bacterial infections and associated factors in a Kenyan intensive care unit: a cross-sectional study.Ann Clin Microbiol Antimicrob. 2023 Sep 14;22(1):85. doi: 10.1186/s12941-023-00636-5. Ann Clin Microbiol Antimicrob. 2023. PMID: 37710247 Free PMC article.
-
Aligning antimicrobial resistance surveillance with schistosomiasis research: an interlinked One Health approach.Trans R Soc Trop Med Hyg. 2024 Aug 5;118(8):498-504. doi: 10.1093/trstmh/trae035. Trans R Soc Trop Med Hyg. 2024. PMID: 38842743 Free PMC article. Review.
-
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too!".Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0022322. doi: 10.1128/aac.00223-22. Epub 2022 Mar 24. Antimicrob Agents Chemother. 2022. PMID: 35323014 Free PMC article. No abstract available.
References
-
- Butler MS, Gigante V, Sati H, Paulin S, Al-Sulaiman L, Rex JH, Fernandes P, Arias CA, Paul M, Thwaites GE, Czaplewski L, Alm RA, Lienhardt C, Spigelman M, Silver LL, Ohmagari N, Kozlov R, Harbarth S, Beyer P. 2022. Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed. Antimicrob Agents Chemother 66:e01991-21. doi:10.1128/AAC.01991-21. - DOI - PMC - PubMed
-
- World Health Organization. 2017. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organization, Geneva, Switzerland.
-
- CDC. 2019. Antibiotic resistance threats in the United States. CDC, Atlanta, Georgia.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources